Evidence map

TrialDiabetes, obesity & metabolism2015

Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial.

M A Abdul-Ghani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

83 papers cite itlatest 60 shown

2015
2017
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 25425451